UMIN ID: UMIN000050375
Registered date:19/04/2024
The effects of test food intake on improving defecation
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Healthy adults |
Date of first enrollment | 2023/03/10 |
Target sample size | 60 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Ingestion of test food A for 4 weeks Ingestion of test food B for 4 weeks Ingestion of placebo food for 4 weeks |
Outcome(s)
Primary Outcome | Defecation status(number of defecation, days of defecation, form of feces, amount of feces) The Japanese Version of the Constipation Assessment Scale (CAS-MT) |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 64years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | (1) Subjects with a history of diabetes, liver, kidney, digestive, heart, respiratory diseases, peripheral neuropathy, and other serious illness (2) Subjects with diseases currently being treated (3) Subjects who are allergic to food and drugs (4) Subjects who are continuously treated by taking medicines (including OTC and prescription drugs) (excluding external preparation such as compresses and hair growth agents) (5) Pregnant (including those who may be pregnant) or lactating female subjects (6) Subjects who cannot stop taking healthy foods with intestinal regulating action (including foods for specified health use and foods with functional claims) and quasi-drugs during the test period (7) Subjects with consuming too much alcohol or not abstaining from alcohol from the day before the test to the day of the test (8) Subjects who are participating in or will participate in other clinical trials at the start of this study. (9) Other subjects judged by the investigator or the investigator to be inappropriate for the examination |
Related Information
Primary Sponsor | Miura Clinic, Medical Corporation Kanonkai |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Morinaga & Co.,Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | Makoto Terashima |
Address | Higashitenma building 4F, 1-7-17, Higashitenma, Kita-ku, Osaka Japan 530-0044 |
Telephone | 06-4801-8917 |
mterashima@oneness-sup.co.jp | |
Affiliation | Oneness Support Co., Ltd. Clinical Trial Division |
scientific contact | |
Name | Naoki Miura |
Address | Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka Japan |
Telephone | 06-6135-5200 |
info@miura-cl.jp | |
Affiliation | Miura Clinic, Medical Corporation Kanonkai Internal medicine |